Antal and Yeo, who also are members of UCSD’s Moores Cancer Center, say the key to targeting triple-negative breast cancer, or TNBC, is managing a protein called poly (U)-binding splicing factor 60, ...

According to CNIO, among the various kinds of cancer, pancreatic cancer remains one of the deadliest and is a widely known ...

It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help!

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.

Explore how evolving treatment strategies and biomarkers are transforming the management of HER2-positive breast cancer in clinical practice.

A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...

The American Cancer Society released its 2026 Facts & Figures, revealing that, for the first time ever, seven in ten cancer ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Purdue researchers identify the PACT protein as a potential target for triple-negative breast cancer, opening new paths for ...